188 related articles for article (PubMed ID: 34739797)
1. The Importance of Nanomedicine in Prophylactic and Theranostic Intervention of Bacterial Zoonoses and Reverse Zoonoses in the Era of Microbial Resistance.
Prasad M; Ghosh M; Kumar R; Brar B; Surjith KP; Lambe UP; Ranjan K; Banerjee S; Prasad G; Kumar Khurana S; Kharb P
J Nanosci Nanotechnol; 2021 Jun; 21(6):3404-3452. PubMed ID: 34739797
[TBL] [Abstract][Full Text] [Related]
2. An Insight into Nanomedicinal Approaches to Combat Viral Zoonoses.
Minakshi P; Ghosh M; Kumar R; Brar B; Lambe UP; Banerjee S; Ranjan K; Kumar B; Goel P; Malik YS; Prasad G
Curr Top Med Chem; 2020; 20(11):915-962. PubMed ID: 32209041
[TBL] [Abstract][Full Text] [Related]
3. Nano-antimicrobials: A New Paradigm for Combating Mycobacterial Resistance.
Minakshi P; Ghosh M; Brar B; Kumar R; Lambe UP; Ranjan K; Manoj J; Prasad G
Curr Pharm Des; 2019; 25(13):1554-1579. PubMed ID: 31218956
[TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
5. Bacteriophages as an Alternative Method for Control of Zoonotic and Foodborne Pathogens.
Alomari MMM; Dec M; Urban-Chmiel R
Viruses; 2021 Nov; 13(12):. PubMed ID: 34960617
[TBL] [Abstract][Full Text] [Related]
6. Emerging antibacterial nanomedicine for enhanced antibiotic therapy.
Wang S; Gao Y; Jin Q; Ji J
Biomater Sci; 2020 Dec; 8(24):6825-6839. PubMed ID: 32996490
[TBL] [Abstract][Full Text] [Related]
7. Novel Nanotherapeutics as Next-generation Anti-infective Agents: Current Trends and Future Prospectives.
Subhaswaraj P; Syed A; Siddhardha B
Curr Drug Discov Technol; 2020; 17(4):457-468. PubMed ID: 31309893
[TBL] [Abstract][Full Text] [Related]
8. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.
Magiorakos AP; Srinivasan A; Carey RB; Carmeli Y; Falagas ME; Giske CG; Harbarth S; Hindler JF; Kahlmeter G; Olsson-Liljequist B; Paterson DL; Rice LB; Stelling J; Struelens MJ; Vatopoulos A; Weber JT; Monnet DL
Clin Microbiol Infect; 2012 Mar; 18(3):268-81. PubMed ID: 21793988
[TBL] [Abstract][Full Text] [Related]
9. Theranostic platforms for specific discrimination and selective killing of bacteria.
Ye X; Feng T; Li L; Wang T; Li P; Huang W
Acta Biomater; 2021 Apr; 125():29-40. PubMed ID: 33582362
[TBL] [Abstract][Full Text] [Related]
10. Applying definitions for multidrug resistance, extensive drug resistance and pandrug resistance to clinically significant livestock and companion animal bacterial pathogens.
Sweeney MT; Lubbers BV; Schwarz S; Watts JL
J Antimicrob Chemother; 2018 Jun; 73(6):1460-1463. PubMed ID: 29481657
[TBL] [Abstract][Full Text] [Related]
11. Extremely and pandrug-resistant bacteria extra-deaths: myth or reality?
Abat C; Fournier PE; Jimeno MT; Rolain JM; Raoult D
Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1687-1697. PubMed ID: 29956024
[TBL] [Abstract][Full Text] [Related]
12. Occurrence of potentially zoonotic and cephalosporin resistant enteric bacteria among shelter dogs in the Central and South-Central Appalachia.
Verma A; Carney K; Taylor M; Amsler K; Morgan J; Gruszynski K; Erol E; Carter C; Locke S; Callipare A; Shah DH
BMC Vet Res; 2021 Sep; 17(1):313. PubMed ID: 34563197
[TBL] [Abstract][Full Text] [Related]
13. "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era.
Huh AJ; Kwon YJ
J Control Release; 2011 Dec; 156(2):128-45. PubMed ID: 21763369
[TBL] [Abstract][Full Text] [Related]
14. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
Bar-Zeev M; Livney YD; Assaraf YG
Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
[TBL] [Abstract][Full Text] [Related]
15. Role of veterinary medicine in public health: antibiotic use in food animals and humans and the effect on evolution of antibacterial resistance.
Lathers CM
J Clin Pharmacol; 2001 Jun; 41(6):595-9. PubMed ID: 11402627
[TBL] [Abstract][Full Text] [Related]
16. Resistance to antimicrobial agents used for animal therapy in pathogenic-, zoonotic- and indicator bacteria isolated from different food animals in Denmark: a baseline study for the Danish Integrated Antimicrobial Resistance Monitoring Programme (DANMAP).
Aarestrup FM; Bager F; Jensen NE; Madsen M; Meyling A; Wegener HC
APMIS; 1998 Aug; 106(8):745-70. PubMed ID: 9744762
[TBL] [Abstract][Full Text] [Related]
17. Extensively drug-resistant and pandrug-resistant Gram-negative bacteria in a tertiary-care hospital in Eastern India: A 4-year retrospective study.
Mohapatra DP; Debata NK; Singh SK
J Glob Antimicrob Resist; 2018 Dec; 15():246-249. PubMed ID: 30144638
[TBL] [Abstract][Full Text] [Related]
18. Broadening the spectrum of small-molecule antibacterials by metallic nanoparticles to overcome microbial resistance.
Rai M; Ingle AP; Pandit R; Paralikar P; Gupta I; Chaud MV; Dos Santos CA
Int J Pharm; 2017 Oct; 532(1):139-148. PubMed ID: 28870767
[TBL] [Abstract][Full Text] [Related]
19. Liposomes as Antibiotic Delivery Systems: A Promising Nanotechnological Strategy against Antimicrobial Resistance.
Ferreira M; Ogren M; Dias JNR; Silva M; Gil S; Tavares L; Aires-da-Silva F; Gaspar MM; Aguiar SI
Molecules; 2021 Apr; 26(7):. PubMed ID: 33918529
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
